Patents Assigned to CHENGDU SINTANOVO BIOTECHNOLOGY CO., LTD.
  • Publication number: 20240158438
    Abstract: A polypeptide compound having a structure shown in formula I, or a stereoisomer, mixture or pharmaceutically acceptable salt thereof Experimental results show that the polypeptide compound can effectively exhibit high agonistic activity to GHSR-1a.
    Type: Application
    Filed: March 25, 2022
    Publication date: May 16, 2024
    Applicant: CHENGDU SINTANOVO BIOTECHNOLOGY CO., LTD.
    Inventors: Guangpeng MENG, Xiaoping FU, Sijun LI, Haoyu MA, Yin ZHANG, Shuang LIU, Miao XU, Jian GAO, Yuanbo LI
  • Patent number: 11643436
    Abstract: The present invention discloses a polypeptide compound, a pharmaceutical composition, and a preparation method and use thereof. The structural formula of the polypeptide compound is shown in general formula (I): Such polypeptide compounds as ?-opioid receptor agonists have the advantages of better activity and the potential to become clinical candidate compounds.
    Type: Grant
    Filed: November 9, 2020
    Date of Patent: May 9, 2023
    Assignee: CHENGDU SINTANOVO BIOTECHNOLOGY CO., LTD.
    Inventors: Jian Gao, Xiaoping Fu, Guoqing Zhong, Haibo Zhou, Hai Hu, Xi Hu, Yu Yuan, Yuanbo Li, Sijun Li
  • Publication number: 20210139537
    Abstract: The present invention discloses a polypeptide compound, a pharmaceutical composition, and a preparation method and use thereof. The structural formula of the polypeptide compound is shown in general formula (I): Such polypeptide compounds as ?-opioid receptor agonists have the advantages of better activity and the potential to become clinical candidate compounds.
    Type: Application
    Filed: November 9, 2020
    Publication date: May 13, 2021
    Applicant: CHENGDU SINTANOVO BIOTECHNOLOGY CO., LTD.
    Inventors: Jian GAO, Xiaoping FU, Guoqing ZHONG, Haibo ZHOU, Hai HU, Xi HU, Yu YUAN, Yuanbo LI